bioRxivBiophysics
A new Karyopherin-β2 binding PY-NLS epitope of HNRNPH2 is linked to neurodevelopmental disorders
A. J. Gonzalez, H. J. Kim, B. D. Freibaum, C. Brautigam, J. P. Taylor, Y. M. Chook
Abstract
The normally nuclear HNRNPH2 is mutated in HNRNPH2-related X-linked neurodevelopmental disorder causing the protein to accumulate in the cytoplasm. Interactions of HNRNPH2 with its importin Karyopherin-{beta}2 (Transportin-1) had not been studied. We present a structure that shows Karyopherin-{beta}2 binding HNRNPH2 residues 204-215, a proline-tyrosine nuclear localization signal or PY-NLS that contains a typical R-X2-4-P-Y motif, 206RPGPY210, followed a new Karyopherin-{beta}2 binding epitope at 211DRP213 that make many interactions with Karyopherin-{beta}2 W373. Mutations at each of these sites decrease Karyopherin-{beta}2 binding affinities by 70-100 fold, explaining aberrant accumulation in cells and emphasizing the role of nuclear import defects in the disease. Sequence/structure analysis suggests that the new epitope C-terminal of the PY-motif, which binds Karyopherin-{beta}2 W373, is rare and thus far limited to close paralogs HNRNPH2, HNRNPH1 and HNRNPF. Karyopherin-{beta}2 W373, a HNRNPH2-binding hotspot, corresponds to W370 of close paralog Transportin-2, a site of pathological variants in patients with neurodevelopmental abnormalities, suggesting that Transportin-2-HNRNPH2/H1/F interactions may be compromised in the abnormalities. SummaryHNRNPH2 variants in HNRNPH2-related X-linked neurodevelopmental disorder aberrantly accumulate in the cytoplasm. A structure of Karyopherin-{beta}2*HNRNPH2 explains nuclear import defects of the variants, reveals a new NLS epitope that suggests mechanistic changes in pathological variants of Karyopherin-{beta}2 paralog Transportin-2.
- organism: human
- assay: protein structure
- research focus: chromatin & epigenetic regulation
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A murine model of hnRNPH2-related neurodevelopmental disorder recapitulates clinical features of human disease and reveals a mechanism for genetic compensation of HNRNPH2
Ané Korff, Xiaojing Yang, … Hong Joo Kim·bioRxiv·Mar 17, 2022
- Disease-associated variants alter a novel physiological role of hnRNP H2 in neuronal development
Afonso Lourinho, Marta S. Silva, … Rui O. Costa·bioRxiv·Oct 8, 2026
- Molecular determinants of Karyopherin-β2 chaperone and disaggregation activity
C. Fare, K. Rhine, … J. Shorter·bioRxiv·Sep 14, 2022
- A candidate HNRNPU-CHD2 RNA-processing axis in neurodevelopmental disease
- Deficiency of the Heterogeneous Nuclear Ribonucleoprotein U locus leads to delayed hindbrain neurogenesis
Francesca Mastropasqua, Marika Oksanen, … Kristiina Tammimies·Biology OpenPeer-reviewed·Oct 10, 2023
- Specific heterozygous frameshift variants in hnRNPA2B1 cause early-onset oculopharyngeal muscular dystrophy
Hong Joo Kim, Payam Mohassel, … J. Paul Taylor·Nature CommunicationsPeer-reviewed·Apr 28, 2022